CV pharm PPT Flashcards

Step 1: draw a picture Step 2: game on Step 3: own it Step 4: repeat steps 2 + 3 until completion

1
Q

What is the result of beta-1 agonism?

A

increased inotropy

increased chronotropy

increased cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the result of beta-2 agonism?

A

peripheral vasodilation (decreasing afterload)

bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the result of alpha-1 agonism?

A

skin, mesenteric, hepatorenal constriction

leading to an increase in afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epinephrine infusion starting dose?

A

0.01 - 0.02 mcg/kg/min

(to a max of 0.3 mcg/kg/min)

(4 mg in 250 mL D5W or NS = 16 mcg/mL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epinephrine pings on what adrenergic receptors?

A

beta-1 and beta-2 (with low doses of 0.01 - 0.04 mcg/kg/min)

alpha-1 (with higher doses, up to 0.3 mcg/kg/min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why can an epinephrine infusion cause mild hypokalemia?

A

d/t the increased activity of the Na/K pump, silly muppet…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Norepinephrine infusion starting dose?

A

0.01 - 0.02 mcg/kg/min

(to a max of 0.3 mcg/kg/min)

(4 mg in 250 mL D5W or NS = 16 mcg/mL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Norepinephrine pings on what adrenergic receptors?

A

beta-1 and beta-2 (beta-1 > beta-2)

alpha-1 (potent effect!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is norepinephrine a good first line drug for low cardiac output in cardiopulmonary bypass?

A

hell yeah it is. use that shit!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Milrinone is what class of drug?

A

a phosphodiesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do phosphodiesterase inhibitors do?

A

phosphodiesterase breaks down cyclic-AMP within the cell.

with inhibition, you have the cAMP building up.

in cardiac muscle this leads to increased inotropy.

in vascular smooth muscle this causes vasodilation.

(may selectively dilate pulmonary greater than the systemic system)

good times…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Will milrinone work in the presence of a beta-blocker?

A

yes.

phosphodiesterase inhibitors are considered “back-door” drugs.

they work within the cell, not at the receptor site outside the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Milrinone loading dose?

A

50 - 75 mcg/kg over 10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Milrinone infusion starting dose?

A

0.375 - 0.75 mcg/kg/min

20 mg in 100mL = 200mcg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is milrinone recommended with MI patients?

A

not at all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nipride infusion starting dose?

A

0.25 - 0.5 mcg/kg/min

(max dose 10 mcg/kg/min)

(50 mg in 250 mL D5W or NS = 200 mcg/mL)

17
Q

How does nipride work?

A

it is a direct nonselective arterial and venous smooth muscle dilator (arterial > venous). because of this, it decreases both preload and afterload.

(direct NO donor, activates guanylyl cyclase, increases cGMP, inhibits Ca++, vascular smooth muscle relaxation)

18
Q

Can nipride inhibit hypoxic pulmonary vasoconstriction?

A

yes, yes it can

19
Q

How does cyanide toxicity occur with nipride? (quick and dirty)

A

nipride interacts with oxyhemoglobin, releasing cyanide and NO, and turns the oxyhemoglobin into methemoglobin

20
Q

Cyanide toxicity causes what?

A

tissue hypoxemia and anearobic metabolism

cyanide toxicity can occur at rates > 2 mcg/kg/min

21
Q

What does amiodarone do?

A

inhibits K+ channels, prolonging action potentials and repolarization

(per the PPT, it also blocks alpha receptors, beta receptors, K+ channels, and Ca++ channels)

(d/t K+ and Ca++ blockade, there are some minor negative inotropic and potent vasodilating effects)

22
Q

Amiodarone is used to treat what?

A

SVT, VT, and A-fib

by depressing AV node and accessory tracts

23
Q

Two side effects of amiodarone. (per the PPT)

A

pulmonary alveolitis

prolonged QT interval

24
Q

What is lidocaine used to treat?

A

PVCs and V-tach

25
Q

What does lidocaine do?

A

decreases AV node and bundle conduction

26
Q

What are toxic lidocaine plasma levels and what can happen?

A

plasma concentration > 5 mcg/mL - seizures

plasma concentration > 10 mcg/mL - CNS depression, apnea, cardiac arrest

27
Q

What is nitric oxide used for?

A

relaxation of the pulmonary vascular smooth muscle.

treatment of cor pulmonale.

decreases PAP and RV afterload.

28
Q

Nitric oxide dose?

A

2 - 40 ppm

rapidly inactivated by Hgb

29
Q

Can nitric oxide improve V/Q mismatching in ARDS patients?

A

yes

30
Q

What is prostacyclin (PGI2) used for?

A

as a potent vasodilator

IV doses to reduce PAP often cause systemic hypotension

31
Q

Which is cheaper, nitric oxide or prostacyclin?

A

prostacyclin

32
Q

Heparin, random facts, go! (3)

A
  • increases antithrombin III
  • doesn’t cross the placenta
  • CPB minimum dose is 300 units/kg (ACT minimum of 400 or 90 - 120 seconds)
33
Q

How many units equal one milligram?

A

100 units / mg

34
Q

Angiomax, random facts, go! (3)

A
  • direct thrombin inhibitor
  • half life of 25 minutes (this is short)
  • eliminated by proteolysis
35
Q

Argatroban, random facts, go! (4)

A
  • direct thrombin inhibitor
  • less potent than bivalirudin
  • pump load 0.05 mg/kg
  • IV load 0.1 mg/kg
36
Q

Dobutamine, fun facts! (3-ish)

A
  • partially selective beta-1, with some beta-2 action
  • < 5 mcg/kg/min - predominant B-1 and B-2 agonism, leading to increased CO and decreased afterload
  • > 5 mcg/kg/min - B-1 and A-1 stimulation, leading to increased CO and stable afterload
37
Q

Dopamine! (5)

A
  • precursor to norepi
  • stimulates: Dop 1, Dop 2, B1, B2, A1
  • low dose: 0.5 - 3 mcg/kg/min (increase pee)
  • moderate dose: 3 - 10 mcg/kg/min (increase pump)
  • high dose: > 10 mcg/kg/min (increase press)
38
Q

IABP, what does it do? (3)

A
  • inflates with helium during diastole
  • increases coronary perfusion
  • deflates before AV opening, decreasing afterload
39
Q

What does using an IABP accomplish? (2)

A
  • increases myocadial O2 supply (diastolic augmentation)

- decreases myocardial O2 demand (reduces afterload)